Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma

The role, optimal dose, and efficacy of radiotherapy (RT) for the treatment of bone metastases in rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) are unclear.

[1]  B. Teh,et al.  Radiotherapy in Metastatic Ewing Sarcoma , 2013, American journal of clinical oncology.

[2]  H. Schoder,et al.  Clinical Investigation : Sarcoma Positron Emission Tomography ( PET ) Evaluation After Initial Chemotherapy and Radiation Therapy Predicts Local Control in Rhabdomyosarcoma , 2022 .

[3]  Arthur K Liu,et al.  Local control of metastatic sites with radiation therapy in metastatic Ewing sarcoma and rhabdomyosarcoma , 2011, Pediatric blood & cancer.

[4]  U. Dirksen,et al.  The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) , 2010, Cancer.

[5]  S. Wolden,et al.  Sarcomas across the age spectrum. , 2010, Seminars in radiation oncology.

[6]  James R. Anderson,et al.  Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  N. Willich,et al.  Whole Lung Irradiation in Patients with Exclusively Pulmonary Metastases of Ewing Tumors , 2008, Strahlentherapie und Onkologie.

[8]  Haesook T. Kim.  Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis , 2007, Clinical Cancer Research.

[9]  J. Healey,et al.  Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. , 2006, International journal of radiation oncology, biology, physics.

[10]  J. Eary,et al.  [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Donaldson,et al.  Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. , 2005, Journal of pediatric surgery.

[12]  M. Carli,et al.  European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  T. Merchant,et al.  Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors. , 2004, International journal of radiation oncology, biology, physics.

[14]  A. Paulino.  Late effects of radiotherapy for pediatric extremity sarcomas. , 2004, International journal of radiation oncology, biology, physics.

[15]  W. Abdullah.  Pediatr Blood Cancer , 2004 .

[16]  J. Meza,et al.  Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  W. Winkelmann,et al.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. , 2003, International journal of radiation oncology, biology, physics.

[18]  James R. Anderson,et al.  Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Meza,et al.  Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. , 2001, International journal of radiation oncology, biology, physics.

[20]  W. Reinus,et al.  A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. , 1998, International journal of radiation oncology, biology, physics.

[21]  W. Winkelmann,et al.  Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  D. Fairclough,et al.  Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  W. Meyer,et al.  Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992. , 1996, Medical and pediatric oncology.

[24]  E. Hall,et al.  Molecular biology in radiation therapy: the potential impact of recombinant technology on clinical practice. , 1994, International journal of radiation oncology, biology, physics.

[25]  E. Gehan,et al.  Ewing's sarcoma metastatic at diagnosis results and comparisons of two intergroup Ewing's sarcoma studies , 1990, Cancer.

[26]  J. Cassady,et al.  Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy , 1976, Cancer.